A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ciclosporin; Mycophenolate mofetil; Tacrolimus
- Indications Liver transplant rejection
- Focus Adverse reactions
- Acronyms AWISH
- 04 Feb 2019 Biomarkers information updated
- 08 Mar 2013 Planned end date changed from 1 Oct 2017 to 1 Nov 2015 as reported by ClinicalTrials.gov.
- 25 Oct 2011 Planned end date changed from 1 Oct 2015 to 1 Oct 2017 as reported by ClinicalTrials.gov.